Researchers found that a one-time gene therapy could potentially help treat Alzheimer’s disease by reducing harmful amyloid plaques in the brain. This new approach, developed by scientists at the Army Medical University in China, delivers a protective gene to the liver rather than trying to penetrate the blood-brain barrier, which has been a challenge for many Alzheimer’s treatments. The study showed that mice receiving this gene therapy experienced a decrease in amyloid plaques and improved cognitive function.

This discovery could be significant for anyone concerned about Alzheimer’s and its effects on memory and cognition. The gene therapy targets the APOE3 Christchurch variant, known for its protective qualities against Alzheimer’s. In the study, male mice with a higher risk variant (APOE4) showed improved performance in memory tests and less brain inflammation after receiving the treatment. This could mean a future where individuals at risk of Alzheimer’s might have a way to delay or prevent the disease’s onset.

The research is still in its early stages, having been tested in mice, and while the results are promising, they are not yet proven in humans. The next steps involve testing this gene therapy in non-human primates before moving to clinical trials. Experts caution that more research is needed to understand how this therapy works and whether it is truly effective compared to other gene variants.

For now, it’s essential to stay informed about developments in Alzheimer’s treatments and consider lifestyle factors that support brain health, such as regular exercise, a balanced diet, and mental stimulation.

Source: fiercebiotech.com